Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zyprexa vs Risperidone on Insulin Sensitivity in Schizophrenia
NCT00190749Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2003
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine in schizophrenia, schizoaffective disorder, sponsored by Eli Lilly and Company. Started Oct 2003; status: completed.
02
Drugs
olanzapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00190749.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00190749.